Akoustis insider plans sale of 4,856 shares

Akoustis Technologies, Inc. (AKTS) has a notice of proposed sale of common stock by an affiliate.

Accepted by SEC EDGAR 07/20/2026 - 04:51 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Akoustis Technologies, Inc. (AKTS) has a notice of proposed sale of common stock by an affiliate. A brokerage account at Morgan Stanley Smith Barney LLC Executive Financial Services is listed for the planned sale of 4,856 shares of common stock on July 20, 2026 on NASDAQ.

The shares are indicated as coming from a stock option exercise, with a stated market value of $119,274.53. The filing also notes that on July 17, 2026, Ken Herrmann sold 3,065 shares of common stock over the prior three months for $77,258.54 in aggregate.

Key Figures

Planned shares to be sold: 4,856 shares Aggregate market value of planned sale: $119,274.53 Shares sold in past 3 months: 3,065 shares +2 more

5 metrics

Planned shares to be sold 4,856 shares Common stock proposed for sale on July 20, 2026

Aggregate market value of planned sale $119,274.53 Value associated with 4,856 shares of common stock

Shares sold in past 3 months 3,065 shares Common stock sale dated July 17, 2026

Aggregate value of past sale $77,258.54 Total consideration for 3,065 shares sold on July 17, 2026

Proposed sale date July 20, 2026 Date for proposed NASDAQ sale of 4,856 shares

Key Terms

stock option exercise, aggregate market value, Form 144

3 terms

stock option exercise financial

"Common | 07/20/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 4856 | 119274.53"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Form 144 regulatory

"144: Securities Information Common ... 144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being registered for Akoustis Technologies (AKTS)?

The notice covers a proposed sale of 4,856 shares of Akoustis Technologies common stock. The shares are expected to be sold on July 20, 2026 through Morgan Stanley Smith Barney LLC on the NASDAQ market.

What is the estimated value of the AKTS shares to be sold under this notice?

The 4,856 shares of Akoustis Technologies common stock are listed with an aggregate market value of $119,274.53. This reflects the value used in the notice of proposed sale, not necessarily the final transaction amount.

How are the Akoustis Technologies (AKTS) shares in this notice being acquired?

The 4,856 shares of Akoustis Technologies common stock are indicated as arising from a stock option exercise. The notice specifies the acquisition method before the planned sale on July 20, 2026.

What recent AKTS stock sales are disclosed for the past three months?

The filing discloses that on July 17, 2026, 3,065 shares of Akoustis Technologies common stock were sold for an aggregate amount of $77,258.54. This transaction is reported as a sale during the past three months.

Who is the selling security holder named in the Akoustis (AKTS) notice?

The selling security holder is identified as Ken Herrmann, with an address at 17 Drydock Avenue, Suite #17-401, Boston, MA 02210. His proposed sale of Akoustis common stock is detailed in the notice.

On which market will the Akoustis Technologies (AKTS) shares be sold?

The proposed sale of 4,856 shares of Akoustis Technologies common stock is listed for trading on NASDAQ. The brokerage handling the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002049757
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AKTIS ONCOLOGY, INC.
SEC File Number	001-43047
Address of Issuer	17 DRYDOCK AVENUE SUITE #17-401 BOSTON MASSACHUSETTS 02210
Phone	617-461-4023
Name of Person for Whose Account the Securities are To Be Sold	KEN HERRMANN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4856	119274.53	53404618	07/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2026	Stock Option Exercise	Issuer			4856	07/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KEN HERRMANN 17 DRYDOCK AVENUE SUITE #17-401 BOSTON MA 02210	Common	07/17/2026	3065	77258.54

144: Remarks and Signature

Remarks
Date of Notice	07/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ken Herrmann
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)